In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Ardelyx Inc (NASDAQ: ARDX) closed at $5.44 in the last session, down -3.20% from day before closing price of $5.62. In other words, the price has decreased by -$3.20 from its previous closing price. On the day, 3.27 million shares were traded. ARDX stock price reached its highest trading level at $5.73 during the session, while it also had its lowest trading level at $5.36.
Ratios:
We take a closer look at ARDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.31 and its Current Ratio is at 4.58. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.88.
On March 04, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $14.
H.C. Wainwright Downgraded its Buy to Neutral on November 11, 2024, whereas the target price for the stock was revised from $11 to $5.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when RAAB MICHAEL sold 41,668 shares for $5.36 per share. The transaction valued at 223,199 led to the insider holds 1,635,138 shares of the business.
MOTT DAVID M bought 77,729 shares of ARDX for $388,738 on Feb 24 ’25. The Director now owns 2,015,494 shares after completing the transaction at $5.00 per share. On Feb 20 ’25, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 4,941 shares for $5.62 each. As a result, the insider received 27,783 and left with 303,804 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1296656640 and an Enterprise Value of 1225522816. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.89 while its Price-to-Book (P/B) ratio in mrq is 7.47. Its current Enterprise Value per Revenue stands at 3.673 whereas that against EBITDA is -47.341.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.74, which has changed by -0.32254046 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $9.33, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is 0.88%, while the 200-Day Moving Average is calculated to be -5.39%.
Shares Statistics:
According to the various share statistics, ARDX traded on average about 4.25M shares per day over the past 3-months and 3086890 shares per day over the past 10 days. A total of 238.02M shares are outstanding, with a floating share count of 227.61M. Insiders hold about 4.51% of the company’s shares, while institutions hold 63.65% stake in the company. Shares short for ARDX as of 1740700800 were 29821609 with a Short Ratio of 7.02, compared to 1738281600 on 26625362. Therefore, it implies a Short% of Shares Outstanding of 29821609 and a Short% of Float of 14.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
